Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Canadian Hemodialysis Morbidity Study.

D N Churchill1, D W Taylor, R J Cook

  • 1St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|March 1, 1992
PubMed
Summary

This study found that older age and cardiovascular disease increase mortality risk in hemodialysis patients. Lower serum albumin and certain vascular access types also raise hospitalization risks for end-stage renal disease patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma Exchange for Acute Renal Failure of Myeloma-Logical, Yet Ineffective: Plasma Exchange When Myeloma Presents as Acute Renal Failure. A Randomized, Controlled Trial. Ann Int Medicine 143: 777-784, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Vitamin D status, body composition and glycemic control in an ambulatory population with diabetes and chronic kidney disease.

European journal of clinical nutrition·2015
Same author

DECISION MAKING AND PROBLEM SOLVING. CONTRACT NONR 609(20). TECHN REP 9.

Protein alterations in erythrocytes at low temperatures. Bjorksten Research Foundation·2014
Same author

Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice.

Clinical transplantation·2013
Same author

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.

Parasite immunology·2012

Area of Science:

  • Nephrology
  • Internal Medicine
  • Public Health

Background:

  • End-stage renal disease (ESRD) patients on hemodialysis face significant risks of morbid events and mortality.
  • Understanding these risks is crucial for improving patient outcomes and healthcare management.

Purpose of the Study:

  • To determine the probabilities of specific morbid events and death in patients undergoing hemodialysis.
  • To identify key risk factors associated with mortality and morbidity in this population.

Main Methods:

  • A prospective cohort study was conducted across 18 hemodialysis centers in Canada.
  • 496 patients initiating hemodialysis were followed, with survival curves analyzed using Cox proportional hazards regression.

Main Results:

Related Experiment Videos

  • Older age and a history of cardiovascular disease were independent predictors of increased mortality.
  • Cardiovascular disease history and low serum albumin (<30 g/L) were linked to higher risks of nonfatal circulatory events and pulmonary edema.
  • Survival without blood transfusion at 12 months was 47.2% for males and 27.5% for females.
  • Graft vascular access, cardiovascular disease history, low serum albumin, and diabetes/vascular disease as the cause of renal disease increased overall hospitalization probability.

Conclusions:

  • Age and cardiovascular disease are critical factors influencing mortality and morbidity in hemodialysis patients.
  • Serum albumin levels and vascular access type significantly impact hospitalization risks and specific complications like pulmonary edema.
  • These findings highlight the need for targeted interventions and vigilant monitoring in the hemodialysis population.